120 related articles for article (PubMed ID: 21542675)
1. Estimation of resource utilisation difference between lithium and valproate treatment groups from the VALID study.
Li SC; Aggarwal SK
J Med Econ; 2011; 14(3):350-6. PubMed ID: 21542675
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of valproate versus lithium in mania or mixed mania: a randomized, open 12-week trial.
Bowden CL; Mosolov S; Hranov L; Chen E; Habil H; Kongsakon R; Manfredi R; Lin HN
Int Clin Psychopharmacol; 2010 Mar; 25(2):60-7. PubMed ID: 20101186
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness and medical costs of divalproex versus lithium in the treatment of bipolar disorder: results of a naturalistic clinical trial.
Revicki DA; Hirschfeld RM; Ahearn EP; Weisler RH; Palmer C; Keck PE
J Affect Disord; 2005 Jun; 86(2-3):183-93. PubMed ID: 15935238
[TBL] [Abstract][Full Text] [Related]
4. The effect of adjunctive mood stabilizers on antipsychotic utilization pattern and health resource utilization for Medicaid enrollees with schizophrenia.
Chen H; Kennedy WK; Dorfman JH; Fincham JE; Reeves J; Martin BC
Curr Med Res Opin; 2007 Jun; 23(6):1351-65. PubMed ID: 17559734
[TBL] [Abstract][Full Text] [Related]
5. A 12-week, open, randomized trial comparing sodium valproate to lithium in patients with bipolar I disorder suffering from a manic episode.
Bowden C; Göğüş A; Grunze H; Häggström L; Rybakowski J; Vieta E
Int Clin Psychopharmacol; 2008 Sep; 23(5):254-62. PubMed ID: 18703934
[TBL] [Abstract][Full Text] [Related]
6. Initial triple therapy of acute mania, adding lithium and valproate to neuroleptics.
Reischies FM; Hartikainen J; Berghöfer AM
Pharmacopsychiatry; 2002 Nov; 35(6):244-6. PubMed ID: 12518274
[TBL] [Abstract][Full Text] [Related]
7. Health-economic implications of the onset of action of antimanic agents.
Keck PE; McElroy SL; Bennett JA
J Clin Psychiatry; 1996; 57 Suppl 13():13-8; discussion 19-22. PubMed ID: 8970501
[TBL] [Abstract][Full Text] [Related]
8. [Valproate in the treatment of bipolar disorder].
Rzewuska M
Psychiatr Pol; 2002; 36(2):239-57. PubMed ID: 12043042
[TBL] [Abstract][Full Text] [Related]
9. One-year rehospitalization rates of patients with first-episode bipolar mania receiving lithium or valproate and adjunctive atypical antipsychotics.
Woo YS; Bahk WM; Jung YE; Jeong JH; Lee HB; Won SH; Lee KH; Jon DI; Yoon BH; Kim MD; Min KJ
Psychiatry Clin Neurosci; 2014 Jun; 68(6):418-24. PubMed ID: 24506520
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.
Salloum IM; Cornelius JR; Daley DC; Kirisci L; Himmelhoch JM; Thase ME
Arch Gen Psychiatry; 2005 Jan; 62(1):37-45. PubMed ID: 15630071
[TBL] [Abstract][Full Text] [Related]
11. Chronic treatment with both lithium and sodium valproate may normalize phosphoinositol cycle activity in bipolar patients.
Silverstone PH; Wu RH; O'Donnell T; Ulrich M; Asghar SJ; Hanstock CC
Hum Psychopharmacol; 2002 Oct; 17(7):321-7. PubMed ID: 12415549
[TBL] [Abstract][Full Text] [Related]
12. Valproate in bipolar disorder: 2000 onwards.
Bowden CL; Singh V
Acta Psychiatr Scand Suppl; 2005; (426):13-20. PubMed ID: 15833096
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126).
Vieta E; Suppes T; Eggens I; Persson I; Paulsson B; Brecher M
J Affect Disord; 2008 Aug; 109(3):251-63. PubMed ID: 18579216
[TBL] [Abstract][Full Text] [Related]
14. [Prophylactic treatment of mood disorders: cost effectiveness analysis comparing lithium and carbamazepine].
Dardennes R; Lafuma A; Watkins S
Encephale; 1999; 25(5):391-400. PubMed ID: 10598301
[TBL] [Abstract][Full Text] [Related]
15. Divalproex in the treatment of bipolar disorder.
Keck PE; McElroy SL
Psychopharmacol Bull; 2003; 37 Suppl 2():67-73. PubMed ID: 15021862
[TBL] [Abstract][Full Text] [Related]
16. The relationship between antimanic agent for treatment of classic or dysphoric mania and length of hospital stay.
Frye MA; Altshuler LL; Szuba MP; Finch NN; Mintz J
J Clin Psychiatry; 1996 Jan; 57(1):17-21. PubMed ID: 8543542
[TBL] [Abstract][Full Text] [Related]
17. Ziprasidone HCl capsules for the adjunctive maintenance treatment of bipolar disorder in adults.
Citrome L
Expert Rev Neurother; 2010 Jul; 10(7):1031-7. PubMed ID: 20586686
[TBL] [Abstract][Full Text] [Related]
18. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.
McIntyre RS; Konarski JZ; Jones M; Paulsson B
J Affect Disord; 2007; 100 Suppl 1():S5-14. PubMed ID: 17391773
[TBL] [Abstract][Full Text] [Related]
19. Pharmacoeconomic and health outcome comparison of lithium and divalproex in a VA geriatric nursing home population: influence of drug-related morbidity on total cost of treatment.
Conney J; Kaston B
Am J Manag Care; 1999 Feb; 5(2):197-204. PubMed ID: 10346515
[TBL] [Abstract][Full Text] [Related]
20. Decision model for the acute treatment of mania.
Steffens DC; Krishnan KR
Depress Anxiety; 1996-1997; 4(6):289-93. PubMed ID: 9166657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]